Related Experiment Video
Updated: Jul 17, 2026
Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
[Screening for retinopathy of prematurity--qualification criteria on the basis of our experience]
Wojciech Hautz1, Mirosława Grałek, Anna Dobrzańska
1Kliniki Okulistyki Instytutu "Pomnik - Centrum Zdrowia Dziecka" w Warszawie.
Insights
Early screening for retinopathy of prematurity (ROP) is crucial for preventing blindness in premature infants. In Poland, screening should focus on infants born before 34 weeks gestation or weighing under 2000 grams, with the first exam at 4 weeks old.
Area of Science:
- Ophthalmology
- Neonatology
- Public Health
Context:
- Retinopathy of prematurity (ROP) is a leading cause of preventable blindness in premature infants.
- Timely laser treatment is effective but requires precise screening protocols.
- Current screening guidelines in Poland require optimization.
Purpose:
- To establish evidence-based principles for ophthalmic screening for ROP in Poland.
- To identify high-risk premature infants requiring ROP screening.
- To determine optimal timing for the initial ROP examination.
Summary:
- A study analyzed 267 premature newborns with stage 3 ROP treated with laser coagulation.
- Infants had birth weights from 490-1980g and gestational ages from 23-34 weeks.
- Laser treatment occurred between 25-147 days of life.
Impact:
- Recommends ROP screening for infants born before or at 34 weeks gestation and those weighing less than 2000 grams.
- Suggests the first ophthalmic examination for ROP should occur within the first 4 weeks of life.
- Aims to improve early detection and treatment of ROP, reducing the risk of blindness in premature infants.
Abstract:
Retinopathy of prematurity is a serious disease which may cause blindness. Modern laser treatment is effective but must be done in right time. The aim of the work is to answer the question: what principles should be used in ophthalmic screening in Poland. 267 premature newborn with 3rd stage of ROP treated with laser coagulation were taken into account. Birth weight of treated children ranged from 490 to 1980 grams, gestation age ranged from 23 to 34 weeks. Laser photocoagulation was carried out between 25 and 147 days of life. Analysis of the above data leads to the following conclusions: compulsory screening for ROP in Poland should be limited to all children born before or in 34 week of gestation and children with birth weight less than 2000 grams; first examination should take place in the 4th week of life.
